← Leaderboards
Richard A Slayden
Colorado State University-Fort Collins
$5,954,059
Attributed
$5,954,059
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$5,954,059 · 6
By mechanism
U54$3,080,759 · 4
U01$1,958,105 · 1
R01$915,195 · 1
Top collaborators
No co-investigators on record.
Most similar at Colorado State University-Fort Collins
Same institution · by research overlap
- Herbert P. Schweizer$10,215,772
- Carol D Blair$7,724,005
- Dean C Crick$6,993,235
- Brian David Foy$8,995,321
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignPathogenBaseBiodefenseResourcesFrancisella TularensisInfectionProgramsYersinia PestisInhibitor/AntagonistAnimal ModelAnti-Bacterial AgentsAnimalsFatty Acid BiosynthesisMolecular ModelingLeadEnzymesMelioidosisIn VitroAffinityBiological AvailabilityEnoyl ReductaseBurkholderia PseudomalleiIn Vivo
Grant awards (19)
Development of novel broad spectrum chemotherapeutics against priority pathogens$349,031
U54 · FY2013 · AI · contact PI
Development of novel broad spectrum chemotherapeutics against priority pathogens$299,871
U54 · FY2012 · AI · contact PI
Development of novel broad spectrum chemotherapeutics against priority pathogens$340,716
U54 · FY2011 · AI · contact PI
Genomics Proteomics Core$196,829
U54 · FY2011 · AI · contact PI
Development and Formulation of Broad Spectrum Antimicrobials for Biodefense$978,895
U01 · FY2010 · AI · contact PI
Development of novel broad spectrum chemotherapeutics against priority pathogens$383,543
U54 · FY2010 · AI · contact PI
Genomics Proteomics Core$220,982
U54 · FY2010 · AI · contact PI
Development and Formulation of Broad Spectrum Antimicrobials for Biodefense$979,210
U01 · FY2009 · AI · contact PI
Development of novel broad spectrum chemotherapeutics against priority pathogens$332,660
U54 · FY2009 · AI · contact PI
Genomics Proteomics Core$191,049
U54 · FY2009 · AI · contact PI
Post Genomic Bioinformatic Core$167,857
U54 · FY2008 · AI · contact PI
Development of Novel Chemotherapeutics Against F. tularensis$138,888
U54 · FY2008 · AI · contact PI
Post Genomic Bioinformatic Core$184,336
U54 · FY2007 · AI · contact PI
Regulation of Cellular division in M. tuberculosis$209,701
R01 · FY2006 · AI · contact PI
Post Genomic Bioinformatic Core$137,010
U54 · FY2006 · AI · contact PI
Regulation of Cellular division in M. tuberculosis$214,748
R01 · FY2005 · AI
Post Genomic Bioinformatic Core$137,987
U54 · FY2005 · AI
Regulation of Cellular division in M. tuberculosis$239,748
R01 · FY2004 · AI
Regulation of Cellular division in M. tuberculosis$250,998
R01 · FY2003 · AI